Literature DB >> 31280491

Postoperative complications in combined gynecologic, plastic, and breast surgery: An analysis from National Surgical Quality Improvement Program.

Sarah E Tevis1, Jennifer G Steiman2, Heather B Neuman3, Caprice C Greenberg3, Lee G Wilke3.   

Abstract

Patients undergoing the addition of a contralateral prophylactic mastectomy with unilateral breast cancer have an increased and potentially doubled post-operative complication rate. One documented detriment from post-operative complications is the potential delay in initiating adjuvant therapy. To determine if the addition of a gynecologic and/or plastic reconstructive procedure to breast surgery results in an increased risk of postoperative complications and re-admissions, we evaluated outcomes in patients undergoing single vs multi-site surgery in a large national surgical database. We utilized the National Surgery Quality Improvement Program (NSQIP) database to identify patients who underwent breast surgery between 2011 and 2015. We extracted patients who underwent prophylactic oophorectomy with or without hysterectomy as a comparison group. Chi square analysis was used to assess postoperative outcomes including complications, readmission, and reoperation. All statistics were performed in SPSS v. 24. During the study timeframe, 77 030 patients had a solitary or combined breast surgical procedure and a second cohort of 124 patients underwent gynecologic surgery. Breast cancer patients who did not have a simultaneous reconstruction or gynecologic procedure were older with more comorbidities. Patients undergoing coordinated procedures had a significantly longer length of stay, higher complication, readmission, and reoperation rates (P < 0.001 for all) as compared with patients who underwent single site surgery. Patients with surgery for breast cancer, either with a plastic or gynecologic procedure, have greater postoperative complications. Higher complication rates for those with coordinated operations may lead to delays in adjuvant therapy and discussions regarding the indications for simultaneous surgery are recommended.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  combined breast surgery

Mesh:

Year:  2019        PMID: 31280491      PMCID: PMC7192577          DOI: 10.1111/tbj.13429

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  11 in total

1.  Is the American College of Surgeons National Surgical Quality Improvement Program surgical risk calculator applicable for breast cancer patients undergoing breast-conserving surgery?

Authors:  Brian Lyle; Jeffrey Landercasper; Jeanne M Johnson; Mohammed Al-Hamadani; Choua A Vang; Jacqueline Groshek; Joy L Hennessy; Lonna M Theede; Kristin Zutavern; Jared H Linebarger
Journal:  Am J Surg       Date:  2015-09-28       Impact factor: 2.565

Review 2.  The relationship between time to initiation of adjuvant chemotherapy and survival in breast cancer: a systematic review and meta-analysis.

Authors:  Michael J Raphael; James J Biagi; Weidong Kong; Mihaela Mates; Christopher M Booth; William J Mackillop
Journal:  Breast Cancer Res Treat       Date:  2016-09-08       Impact factor: 4.872

3.  Incremental risk associated with contralateral prophylactic mastectomy and the effect on adjuvant therapy.

Authors:  Dustin L Eck; Galen Perdikis; Bhupendra Rawal; Sanjay Bagaria; Sarah A McLaughlin
Journal:  Ann Surg Oncol       Date:  2014-07-22       Impact factor: 5.344

4.  Comparing Coordinated Versus Sequential Salpingo-Oophorectomy for BRCA1 and BRCA2 Mutation Carriers With Breast Cancer.

Authors:  Jocelyn S Chapman; Erika Roddy; Anna Panighetti; Shelley Hwang; Beth Crawford; Bethan Powell; Lee-May Chen
Journal:  Clin Breast Cancer       Date:  2016-07-05       Impact factor: 3.225

5.  Early Postoperative Outcomes in Breast Conservation Surgery Versus Simple Mastectomy with Implant Reconstruction: A NSQIP Analysis of 11,645 Patients.

Authors:  Bryan Pyfer; Abhishek Chatterjee; Lilian Chen; John Nigriny; Brian Czerniecki; Julia Tchou; Carla Fisher
Journal:  Ann Surg Oncol       Date:  2015-07-29       Impact factor: 5.344

6.  Laparoscopic oophorectomy in the management of breast disease.

Authors:  Peter Willsher; Ahmad Ali; Lee Jackson
Journal:  ANZ J Surg       Date:  2008-08       Impact factor: 1.872

7.  Increased postoperative complications in bilateral mastectomy patients compared to unilateral mastectomy: an analysis of the NSQIP database.

Authors:  Fahima Osman; Fady Saleh; Timothy D Jackson; Mark A Corrigan; Tulin Cil
Journal:  Ann Surg Oncol       Date:  2013-07-12       Impact factor: 5.344

8.  Outcomes and Cost Analysis in High-Risk Patients Undergoing Simultaneous Free Flap Breast Reconstruction and Gynecologic Procedures.

Authors:  Gabriel A Del Corral; Ari M Wes; John P Fischer; Joseph M Serletti; Liza C Wu
Journal:  Ann Plast Surg       Date:  2015-11       Impact factor: 1.539

9.  Coordinated prophylactic surgical management for women with hereditary breast-ovarian cancer syndrome.

Authors:  Larissa I Batista; Karen H Lu; Elisabeth K Beahm; Banu K Arun; Diane C Bodurka; Funda Meric-Bernstam
Journal:  BMC Cancer       Date:  2008-04-14       Impact factor: 4.430

Review 10.  Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survival in breast cancer: a systematic review and meta-analysis.

Authors:  Ke-Da Yu; Sheng Huang; Jia-Xin Zhang; Guang-Yu Liu; Zhi-Ming Shao
Journal:  BMC Cancer       Date:  2013-05-16       Impact factor: 4.430

View more
  2 in total

1.  National perspective on hospital readmissions following adrenalectomy.

Authors:  Mohammed Hussein; Eman Toraih; Ahmed Mahmoud Fouad; Lauren Mueller; Alexander Blum; Zaid Al-Qurayshi; Jeffrey Borchardt; Emad Kandil
Journal:  Gland Surg       Date:  2022-06

2.  Synchronous surgery and immediate reconstruction of double primary cancers of the ovary and breast.

Authors:  Chao-Hsin Huang; Yur-Ren Kuo; Yu-Chieh Chen; Shen-Liang Shih
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.